These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 7688103

  • 1. Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL/MpJ-lpr/lpr mice.
    Entani C, Izumino K, Iida H, Fujita M, Asaka M, Takata M, Sasayama S.
    Nephron; 1993; 64(3):471-5. PubMed ID: 7688103
    [Abstract] [Full Text] [Related]

  • 2. FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice.
    Furukawa F, Imamura S, Takigawa M.
    Arch Dermatol Res; 1995; 287(6):558-63. PubMed ID: 7487142
    [Abstract] [Full Text] [Related]

  • 3. Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models.
    Sugahara K, Maeda Y, Shimano K, Murase M, Mochiduki S, Takemoto K, Kakimoto T, Utsumi H, Oshita K, Kataoka H.
    J Immunol Res; 2019; 2019():5821589. PubMed ID: 31930150
    [Abstract] [Full Text] [Related]

  • 4. Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis.
    Liao R, Liu Q, Zheng Z, Fan J, Peng W, Kong Q, He H, Yang S, Chen W, Tang X, Yu X.
    PLoS One; 2015; 10(7):e0132724. PubMed ID: 26161538
    [Abstract] [Full Text] [Related]

  • 5. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease.
    Pérez de Lema G, Lucio-Cazaña FJ, Molina A, Luckow B, Schmid H, de Wit C, Moreno-Manzano V, Banas B, Mampaso F, Schlöndorff D.
    Kidney Int; 2004 Sep; 66(3):1018-28. PubMed ID: 15327395
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic effect of 15-deoxyspergualin on the progression of lupus nephritis in MRL mice. I. Immunopathological analyses.
    Ito S, Ueno M, Arakawa M, Saito T, Aoyagi T, Fujiwara M.
    Clin Exp Immunol; 1990 Sep; 81(3):446-53. PubMed ID: 2397613
    [Abstract] [Full Text] [Related]

  • 7. The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice.
    Shi Y, Yao W, Sun L, Li G, Liu H, Ding P, Hu W, Xu H.
    BMC Nephrol; 2019 Nov 21; 20(1):424. PubMed ID: 31752725
    [Abstract] [Full Text] [Related]

  • 8. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S.
    J Rheumatol; 2002 Apr 21; 29(4):707-16. PubMed ID: 11950011
    [Abstract] [Full Text] [Related]

  • 9. IL-3 contributes to development of lupus nephritis in MRL/lpr mice.
    Renner K, Hermann FJ, Schmidbauer K, Talke Y, Rodriguez Gomez M, Schiechl G, Schlossmann J, Brühl H, Anders HJ, Mack M.
    Kidney Int; 2015 Nov 21; 88(5):1088-98. PubMed ID: 26131743
    [Abstract] [Full Text] [Related]

  • 10. Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation.
    He J, Sun M, Tian S.
    Innate Immun; 2018 Jul 21; 24(5):307-315. PubMed ID: 29874961
    [Abstract] [Full Text] [Related]

  • 11. (5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/lpr mice by preventing infiltration of immune cells.
    Zhang LY, Li H, Wu YW, Cheng L, Yan YX, Yang XQ, Zhu FH, He SJ, Tang W, Zuo JP.
    Am J Physiol Renal Physiol; 2017 Apr 01; 312(4):F769-F777. PubMed ID: 28100505
    [Abstract] [Full Text] [Related]

  • 12. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B.
    J Am Soc Nephrol; 2005 Dec 01; 16(12):3592-601. PubMed ID: 16267157
    [Abstract] [Full Text] [Related]

  • 13. Experimental treatment of autoimmune MRL-lpr/lpr mice with immunosuppressive compound FK506.
    Yamamoto K, Mori A, Nakahama T, Ito M, Okudaira H, Miyamoto T.
    Immunology; 1990 Feb 01; 69(2):222-7. PubMed ID: 1689694
    [Abstract] [Full Text] [Related]

  • 14. Microthrombotic Renal Vascular Lesions Are Associated to Increased Renal Inflammatory Infiltration in Murine Lupus Nephritis.
    Gonzalo-Gil E, García-Herrero C, Toldos O, Usategui A, Criado G, Pérez-Yagüe S, Barber DF, Pablos JL, Galindo M.
    Front Immunol; 2018 Feb 01; 9():1948. PubMed ID: 30210500
    [Abstract] [Full Text] [Related]

  • 15. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice.
    Elliott MK, Jarmi T, Ruiz P, Xu Y, Holers VM, Gilkeson GS.
    Kidney Int; 2004 Jan 01; 65(1):129-38. PubMed ID: 14675043
    [Abstract] [Full Text] [Related]

  • 16. Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice.
    Zhang Z, Liu D, Zhang X, Wang X.
    Inflammation; 2018 Oct 01; 41(5):1888-1899. PubMed ID: 29951872
    [Abstract] [Full Text] [Related]

  • 17. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
    Jiang C, Zhao ML, Scearce RM, Diaz M.
    Arthritis Rheum; 2011 Apr 01; 63(4):1086-96. PubMed ID: 21225690
    [Abstract] [Full Text] [Related]

  • 18. Intermittent Fasting Aggravates Lupus Nephritis through Increasing Survival and Autophagy of Antibody Secreting Cells in MRL/lpr Mice.
    Hong SM, Lee J, Jang SG, Song Y, Kim M, Lee J, Cho ML, Kwok SK, Park SH.
    Int J Mol Sci; 2020 Nov 11; 21(22):. PubMed ID: 33187196
    [Abstract] [Full Text] [Related]

  • 19. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.
    J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682
    [Abstract] [Full Text] [Related]

  • 20. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
    Sadanaga A, Nakashima H, Masutani K, Miyake K, Shimizu S, Igawa T, Sugiyama N, Niiro H, Hirakata H, Harada M.
    Arthritis Rheum; 2005 Dec 15; 52(12):3987-96. PubMed ID: 16320345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.